Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Cancer Control. 2021 Jan-Dec;28:10732748211038734. doi: 10.1177/10732748211038734.
The current number of breast cancer survivors (BCS) in the United States is approximately 3.8 million, and this number is further expected to increase with improvement in treatments. Survivorship care plans (SCPs) are patient-centered tools that are designed to meet cancer survivors' informational needs about their treatment history, recommended health care, and health maintenance. However, the data on SCP benefits remain uncertain, especially in low-income and racial and ethnic minority cancer survivors. Patient navigation is an effective intervention to improve patient adherence and experience of interdisciplinary breast cancer treatment.
This study sought to understand the role of lay patient navigators (LPN) in survivorship care planning for BCS in safety-net settings.
This study is a mixed methods pilot randomized clinical trial to understand the role of patient navigation in cancer survivorship care planning in a public hospital. We invited BCS who had completed active breast cancer treatment within 5 years. LPNs discussed survivorship care planning and survivorship care-related issues with BCS in the intervention arm over a 6-month intervention period and accompanied patients to their primary care appointment. LPNs also encouraged survivors to discuss health care issues with oncology and primary care providers. The primary objective was to assess BCS' health-related quality of life (HRQOL). The secondary objectives were self-efficacy and implementation. We assessed implementation with 45-60-min semi-structured interviews with 15 BCS recruited from the intervention arm and 60-min focus groups with the oncologists and separately with LPNs.
We enrolled 40 patients, 20 randomized to usual care and 20 randomized to LPN navigation. We did not find a statistically significant difference between the two arms in HRQOL. There was also no difference in self-efficacy between the two arms. Qualitative analysis identified implementation barriers to intervention that may have contributed to less effective intervention.
Future survivorship care planning interventions need to consider: Cancer survivors' needs and preferences, the need for dedicated resources, and the role of electronic health records in survivorship care plan delivery.
目前美国的乳腺癌幸存者(BCS)人数约为 380 万,随着治疗的改善,这一数字还将进一步增加。生存护理计划(SCP)是以患者为中心的工具,旨在满足癌症幸存者对其治疗史、推荐的医疗保健和健康维护的信息需求。然而,SCP 益处的数据仍然不确定,尤其是在低收入和种族及少数民族癌症幸存者中。患者导航是一种有效的干预措施,可以提高患者对跨学科乳腺癌治疗的依从性和体验。
本研究旨在了解在医疗服务不足的环境中,非专业患者导航员(LPN)在乳腺癌幸存者生存护理计划中的作用。
本研究是一项混合方法的试点随机临床试验,旨在了解患者导航在公立医院的癌症生存护理计划中的作用。我们邀请了在 5 年内完成乳腺癌积极治疗的 BCS。在 6 个月的干预期内,LPN 与干预组的 BCS 讨论生存护理计划和与生存护理相关的问题,并陪同患者进行初级保健预约。LPN 还鼓励幸存者与肿瘤学和初级保健提供者讨论医疗保健问题。主要目标是评估 BCS 的健康相关生活质量(HRQOL)。次要目标是自我效能和实施。我们通过对干预组中招募的 15 名 BCS 进行 45-60 分钟的半结构化访谈和对肿瘤学家进行 60 分钟的焦点小组来评估实施情况,并分别与 LPN 进行了访谈。
我们共招募了 40 名患者,其中 20 名随机分配到常规护理组,20 名随机分配到 LPN 导航组。我们没有发现两组之间在 HRQOL 方面有统计学上的显著差异。两组之间的自我效能也没有差异。定性分析确定了干预实施的障碍,这可能导致干预效果不佳。
未来的生存护理计划干预需要考虑:癌症幸存者的需求和偏好、专用资源的需求以及电子健康记录在生存护理计划提供中的作用。